TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26388534

Group type: EXPERIMENTAL
Intervention: tOPV
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: tOPV plus IPV
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: bOPV
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: bOPV plus IPV
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: bOPV plus 2IPV
Number of subjects: 900
Study: 23769234

Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 2413

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2413
Study: 21491144

Group type: EXPERIMENTAL
Intervention: Technosphere® Insulin (TI) inhalation powder
Number of subjects: 0
Study: 18532963

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises (PFME)
Number of subjects: 4214

Group type: COMPARATOR
Intervention: Caesarean section delivery mode
Number of subjects: 4214

Group type: COMPARATOR
Intervention: Urinary or faecal incontinence
Number of subjects: 4214
Study: 16420706

Group type: EXPERIMENTAL
Intervention: MDD group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 12702132

Group type: EXPERIMENTAL
Intervention: Interferon-alfa-2a (IFN) regimen Group A: 6 mega units (MU) subcutaneously three times a week for 24 weeks, then 3 MU three times a week for the last 24 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Interferon-alfa-2a (IFN) regimen Group B: 9 MU daily for 2 weeks, 3 MU daily for 22 weeks, then 3 MU three times a week for the last 24 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy and HCV mono-infected patients (Control)
Number of subjects: 36
Study: 10878501

Group type: EXPERIMENTAL
Intervention: Cortisol infusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 9
Study: 8883486

Group type: EXPERIMENTAL
Intervention: Mapping-enhanced counseling
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 320
Study: 1419076

Group type: EXPERIMENTAL
Intervention: PGE2 infusion
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Indomethacin (NSAID)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Naproxen (NSAID)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 50
Study: 3831962

Group type: EXPERIMENTAL
Intervention: Intrathecal dermorphine (20 micrograms)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (500 micrograms)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intramuscular pentazocine (30 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intrathecal dermorphine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intramuscular pentazocine
Number of subjects: 150
Study: 31300578

Group type: EXPERIMENTAL
Intervention: Prediction model including age, BMI, mild knee symptoms, knee problems climbing stairs, morning stiffness, postmenopausal status, and heavy work.
Number of subjects: 237
Study: 30312799

Group type: EXPERIMENTAL
Intervention: Oral TXA (1 g given 2 hours before incision, repeated at 3 hours and 6 hours postoperatively)
Number of subjects: 100

Group type: COMPARATOR
Intervention: IV TXA (1 g administered 10 minutes before incision, repeated at 3 hours and 6 hours postoperatively)
Number of subjects: 100
Study: 29392030

Group type: EXPERIMENTAL
Intervention: Radiofrequency thermal ablation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Microdebrider-assisted turbinoplasty
Number of subjects: 40
Study: 25315598

Group type: EXPERIMENTAL
Intervention: Health literacy-focused intervention
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: AHL-C instrument
Number of subjects: 560
Study: 22486226

Group type: EXPERIMENTAL
Intervention: Addition of a pharmacist to primary care teams
Number of subjects: 195

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 195
Study: 20427749

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (up to 40,000 IU/day for 28 weeks, then 10,000 IU/day for 12 weeks, followed by 0 IU/day) with calcium (1,200 mg/day)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (up to 40,000 IU/day)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not receiving high-dose vitamin D)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D
Number of subjects: 49
Study: 17094166

Group type: EXPERIMENTAL
Intervention: Lichtenstein's operation
Number of subjects: 595

Group type: COMPARATOR
Intervention: Mesh plug repair
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 595
Study: 16095500

Group type: EXPERIMENTAL
Intervention: Donor antibody titer
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Kidneys from the same donor
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Kidneys from donors lacking HLA C7
Number of subjects: 198
Study: 12360162

Group type: EXPERIMENTAL
Intervention: COER-verapamil hydrochloride (240 mg titrated to 360 mg)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Enalapril (10 mg titrated to 20 mg)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Losartan (50 mg titrated to 100 mg)
Number of subjects: 357
Study: 10366224

Group type: EXPERIMENTAL
Intervention: ADCA type I (SCA1, SCA2, SCA3)
Number of subjects: 40

Group type: COMPARATOR
Intervention: ADCA type II
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SCA1 patients with polyneuropathy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SCA3/MJD patients
Number of subjects: 40
Study: 7741947

Group type: EXPERIMENTAL
Intervention: Attended prenatal childbirth education classes
Number of subjects: 106

Group type: COMPARATOR
Intervention: Did not attend prenatal childbirth education classes
Number of subjects: 106
Study: 2202790

Group type: EXPERIMENTAL
Intervention: Verbal vignette describing CMF
Number of subjects: 282

Group type: COMPARATOR
Intervention: Numeric vignette describing CMF
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Verbal vignette group divided into thirds based on DFS estimate
Number of subjects: 282
Study: 7013303

Group type: EXPERIMENTAL
Intervention: Metoclopramide (cerucal, 3 x 10 mg p.o.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentagastrin stimulation
Number of subjects: 0
Study: 31743809

Group type: EXPERIMENTAL
Intervention: CHO + Gln (Gln 20 g/d for 6 d and maltodextrin 8%/200 mL for 20 min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CHO + Gln
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: CHO
Number of subjects: 15
Study: 30651194

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Subacromial injection (SA)
Number of subjects: 42
Study: 28728560

Group type: EXPERIMENTAL
Intervention: Patient-oriented education and medication management intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 0
Study: 26469896

Group type: EXPERIMENTAL
Intervention: Amiodarone therapy group (n = 122 patients)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Metoprolol therapy group (n = 129 patients)
Number of subjects: 251
Study: 23694704

Group type: EXPERIMENTAL
Intervention: High illuminance (700 lx)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low illuminance (150 lx)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Illumination conditions (3000 K and 7100 K)
Number of subjects: 0
Study: 21335510

Group type: EXPERIMENTAL
Intervention: 12-week lifestyle program comprising aerobic and resistance exercise, plus dietary advice
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study: 19800193

Group type: EXPERIMENTAL
Intervention: CRT ON (active treatment)
Number of subjects: 262

Group type: COMPARATOR
Intervention: CRT OFF (control treatment)
Number of subjects: 262
Study: 16950955

Group type: EXPERIMENTAL
Intervention: Cocoa husk supplement
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 14687239

Group type: EXPERIMENTAL
Intervention: Intensified cardiovascular risk management for 6 months
Number of subjects: 159

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 159
Study: 10899847

Group type: EXPERIMENTAL
Intervention: Vaccine lot E005
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Vaccine lot E003
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Vaccine lot E005 and E003
Number of subjects: 155
Study: 9018017

Group type: EXPERIMENTAL
Intervention: Acute dietary tryptophan depletion
Number of subjects: 16
Study: 8101082

Group type: EXPERIMENTAL
Intervention: Broxaterol (B) at 0.75 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Broxaterol (B) at 1.25 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Broxaterol (B) at 2.50 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Broxaterol (B) at 1.25 mg, 3 times a day for 1 month
Number of subjects: 36
Study: 3794304

Group type: EXPERIMENTAL
Intervention: 0.5 mg atropine sulfate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10 mg pirenzepine
Number of subjects: 10
Study: 31550941

Group type: EXPERIMENTAL
Intervention: Rituximab and short course corticosteroids (CS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific BTK inhibitors
Number of subjects: 0
Study: 29097487

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 40
Study: 26307162

Group type: EXPERIMENTAL
Intervention: Low dose bacillus Calmette‐Guérin (40 mg)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard dose bacillus Calmette‐Guérin (80 mg)
Number of subjects: 166
Study: 25363101

Group type: EXPERIMENTAL
Intervention: Risperidone plus sodium valproate
Number of subjects: 48

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 48
Study: 24396757

Group type: EXPERIMENTAL
Intervention: Gabapentin 20 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Diclofenac 1.0 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 20589598

Group type: EXPERIMENTAL
Intervention: Clozapine combined with ziprasidone (CZ)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clozapine combined with risperidone (CR)
Number of subjects: 24
Study: 17396066

Group type: EXPERIMENTAL
Intervention: alpha-Lipoic acid and acetyl-L-carnitine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 16344515

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 12162470

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg, 15 mg, 30 mg
Number of subjects: 79

Group type: COMPARATOR
Intervention: Indomethacin (Indo-ER) 75 mg once daily
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 10215212

Group type: EXPERIMENTAL
Intervention: Triblock-copolymer circuit (polycaprolactone-polydimethylsiloxane-polycaprolactone)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control circuit
Number of subjects: 34
Study: 7533343

Group type: EXPERIMENTAL
Intervention: FK506/prednisone (double therapy)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: FK506/azathioprine/prednisone (triple therapy)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Overall (first cadaver transplants)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 204
Study: 2718912

Group type: EXPERIMENTAL
Intervention: 330 kcal/d diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 780 kcal/d diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 323086

Group type: EXPERIMENTAL
Intervention: Calcium dobesylate, 250 mg three times a day (period B)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Calcium dobesylate (period C)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (period D)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Calcium dobesylate and placebo (period C and D)
Number of subjects: 36
Study: 31558866

Group type: EXPERIMENTAL
Intervention: Ropivacaine group (7.5 mg/mL ropivacaine infiltration)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (normal saline 5 mL infiltration)
Number of subjects: 146
Study: 29028286

Group type: EXPERIMENTAL
Intervention: Doppler-guided goal-directed fluid therapy (GDFT)
Number of subjects: 0
Study: 25992820

Group type: EXPERIMENTAL
Intervention: Calendula officinalis
Number of subjects: 51

Group type: COMPARATOR
Intervention: Essential Fatty Acids
Number of subjects: 51
Study: 23482466

Group type: EXPERIMENTAL
Intervention: Corneal deformation amplitude (CDA)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Difference between DCT and GAT measurements
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: IOP difference
Number of subjects: 180
Study: 21795446

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg BID
Number of subjects: 4008

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg QD
Number of subjects: 4008

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4008

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg BID and QD
Number of subjects: 4008
Study: 18800005

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation
Number of subjects: 188

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 188
Study: 16255390

Group type: EXPERIMENTAL
Intervention: Group cue-exposure program to drug-related stimuli (12 treatment sessions, 3 times weekly)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 12408216

Group type: EXPERIMENTAL
Intervention: Therapeutic touch (5 to 7 minutes, 2 times a day for 3 days)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 10
Study: 9935221

Group type: EXPERIMENTAL
Intervention: Preoperative radio‐chemo‐thermo‐therapy (RCTT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Radio‐chemo‐therapy (RCT) without hyperthermia (control group)
Number of subjects: 27
Study: 7778631

Group type: EXPERIMENTAL
Intervention: Tocolysis (intravenous magnesium sulfate and/or oral or subcutaneous beta-sympathomimetics)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Short-term intravenous magnesium alone
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Tocolysis
Number of subjects: 112
Study: 2368684

Group type: EXPERIMENTAL
Intervention: Ward ambulation program
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Dedicated exercise center program
Number of subjects: 51
Study: 6985697

Group type: EXPERIMENTAL
Intervention: Molsidomine (0.03 mg/kg IV) during exercise-induced angina
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Molsidomine (0.03 mg/kg IV) during pacing-induced angina
Number of subjects: 14

Group type: COMPARATOR
Intervention: Molsidomine (2 mg three times daily)
Number of subjects: 14
Study: 31221197

Group type: EXPERIMENTAL
Intervention: ML-Adaptive Boosting
Number of subjects: 3624

Group type: EXPERIMENTAL
Intervention: ML-random forest
Number of subjects: 3624

Group type: COMPARATOR
Intervention: BCRAT
Number of subjects: 3624

Group type: EXPERIMENTAL
Intervention: ML-adaptive boosting
Number of subjects: 3624

Group type: EXPERIMENTAL
Intervention: ML-Markov chain Monte Carlo generalized linear mixed model
Number of subjects: 3624

Group type: COMPARATOR
Intervention: BOADICEA
Number of subjects: 3624
Study: 27928843

Group type: EXPERIMENTAL
Intervention: SIRS after cardiac surgery with cardiopulmonary bypass (CPB)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: SIRS after cardiac surgery without cardiopulmonary bypass (CPB)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Duration of CPB
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Amount of fresh frozen plasma
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Neonates
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: SIRS
Number of subjects: 116
Study: 26433456

Group type: EXPERIMENTAL
Intervention: GMT 2.0 treatment
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 55
Study: 23611375

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine buffered with 5% sodium bicarbonate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine buffered with 10% sodium bicarbonate
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine (nonbuffered)
Number of subjects: 30
Study: 21654441

Group type: EXPERIMENTAL
Intervention: Internet counseling
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Phone counseling
Number of subjects: 1386

Group type: COMPARATOR
Intervention: Control (self-directed materials)
Number of subjects: 1386
Study: 19117888

Group type: EXPERIMENTAL
Intervention: Monthly parenting newsletter (12 issues) containing information on emotional development, parent-child interaction, and play.
Number of subjects: 185

Group type: COMPARATOR
Intervention: Normal parenting support (received by both groups).
Number of subjects: 185
Study: 16434455

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1162
Study: 16009958

Group type: COMPARATOR
Intervention: Preoperative radiotherapy (preop RT) 45 Gy in 5 weeks
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy plus two 5-day chemotherapy courses (fluorouracil 350 mg/m2/d and leucovorin 20 mg/m2/d) in the first and fifth week of RT
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Preoperative radiotherapy plus four postoperative chemotherapy courses
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy and chemotherapy plus postoperative chemotherapy
Number of subjects: 1011
Study: 11888223

Group type: EXPERIMENTAL
Intervention: Hypnosis (standardized eight-session hypnosis treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation (standardized eight sessions of Jacobson's relaxation treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (waiting list)
Number of subjects: 0
Study: 10455902

Group type: EXPERIMENTAL
Intervention: Computer-based training (CBT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Didactic training
Number of subjects: 69

Group type: COMPARATOR
Intervention: Videotape training
Number of subjects: 69
Study: 8778010

Group type: EXPERIMENTAL
Intervention: Transvaginal color Doppler ultrasonography in patients with cervix carcinoma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 0
Study: 2085082

Group type: EXPERIMENTAL
Intervention: Propofol alone (12‐15 mg/kg/h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Propofol with fentanyl supplementation (6‐9 mg/kg/h)
Number of subjects: 20
Study: 380268

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 50
Study: 31694394

Group type: EXPERIMENTAL
Intervention: Genetically determined levels of HDL-C
Number of subjects: 407558

Group type: EXPERIMENTAL
Intervention: HDL-C polygenic score
Number of subjects: 407558

Group type: COMPARATOR
Intervention: LDL-C and triglyceride polygenic scores
Number of subjects: 407558
Study: 30945124

Group type: EXPERIMENTAL
Intervention: Disease-modifying anti-rheumatic drugs (DMARDs)
Number of subjects: 20707

Group type: COMPARATOR
Intervention: Non-DMARD users (Control)
Number of subjects: 20707
Study: 27182679

Group type: EXPERIMENTAL
Intervention: HFR (Hemodiafiltration with endogenous reinfusion)
Number of subjects: 17

Group type: COMPARATOR
Intervention: OLHDF (Online-hemodiafiltration)
Number of subjects: 17
Study: 24696369

Group type: EXPERIMENTAL
Intervention: Stop-smoking medication
Number of subjects: 1319

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (preferred by 85.2% of medication users)
Number of subjects: 1319

Group type: COMPARATOR
Intervention: Modern smoking cessation group programme
Number of subjects: 1319
Study: 23643001

Group type: EXPERIMENTAL
Intervention: Tranexamic acid 10 mg/kg (intravenous injection slowly before skin incision) followed by infusion of normal saline until postoperative 12 hours
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tranexamic acid 10 mg/kg (intravenous injection slowly before skin incision) followed by infusion of tranexamic acid 1 mg/(kg·h) until postoperative 12 hours
Number of subjects: 60
Study: 21134507

Group type: EXPERIMENTAL
Intervention: Contraceptive method change during the trial
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Participant desire/partners' desire for future children
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Age of participants
Number of subjects: 122
Study: 19998582

Group type: EXPERIMENTAL
Intervention: Test drug (Acnez)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Reference drug
Number of subjects: 12
Study: 17465647

Group type: EXPERIMENTAL
Intervention: Corticotomy-assisted technique
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conventional surgical technique
Number of subjects: 6
Study: 15140569

Group type: EXPERIMENTAL
Intervention: Eye movement desensitization and reprocessing method (EMDR)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham treatment (Control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Psychometric assessment after EMDR treatment
Number of subjects: 10
Study: 11796084

Group type: EXPERIMENTAL
Intervention: Single dose of albendazole (400 mg) and praziquantel (40 mg/kg)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 268
Study: 9494455

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics plus intranasal beclomethasone (336 micrograms/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Prophylactic antibiotics
Number of subjects: 61

Group type: COMPARATOR
Intervention: Prophylactic antibiotics plus intranasal placebo
Number of subjects: 61
Study: 7766965

Group type: EXPERIMENTAL
Intervention: A new amino acid mixture incorporated into medical foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Occult monitoring of medical foods purchased
Number of subjects: 0
Study: 10303911

Group type: EXPERIMENTAL
Intervention: Mass mammography screening (specific details on dosage and duration not available)
Number of subjects: 0